Fatty Liver Disease,An Issue of Gastroenterology Clinics of North America, 1st Edition

Author :
Edited by Arun J. Sanyal, MBBS, MD and Mohammad Shadab Siddiqui
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on ...view more
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
ISBN :
9780323682039
Publication Date :
12-02-2020
Add to Cart
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.

Author Information
Edited by Arun J. Sanyal, MBBS, MD, Charles Caravati Professor and Chair , Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia and Mohammad Shadab Siddiqui